201 related articles for article (PubMed ID: 11142571)
1. Infliximab (Remicade): the magic bullet for Crohn's disease?
D'Haens G
Dig Liver Dis; 2000 Nov; 32(8):653-6. PubMed ID: 11142571
[No Abstract] [Full Text] [Related]
2. [Recommendations for the use of infliximab (Remicade) in Crohn's disease. GETECCU 2001].
Domènech E; Esteve-Comas M; Gomollón F; Hinojosa J; Obrador A; Panés J; Gassull MA;
Gastroenterol Hepatol; 2002 Mar; 25(3):162-9. PubMed ID: 11864540
[No Abstract] [Full Text] [Related]
3. Infliximab (Remicade), a new biological treatment for Crohn's disease.
D'Haens GR
Ital J Gastroenterol Hepatol; 1999; 31(6):519-20. PubMed ID: 10575573
[TBL] [Abstract][Full Text] [Related]
4. Infliximab treatment for Crohn's disease.
Conroy CA; Cattell R
Postgrad Med J; 2001 Jul; 77(909):436-40. PubMed ID: 11423591
[No Abstract] [Full Text] [Related]
5. Infliximab: how to use it in pediatric Crohn's disease.
Ruemmele FM
J Pediatr Gastroenterol Nutr; 2004 Jul; 39(1):12-4. PubMed ID: 15187774
[No Abstract] [Full Text] [Related]
6. [Remicade (infliximab) in the treatment of Crohn disease].
Brazier F; Delcenserie R; Dupas JL
Presse Med; 2000 Sep; 29(16):1463-4. PubMed ID: 11039091
[No Abstract] [Full Text] [Related]
7. [Adalimumab in infliximab refractory Crohn's disease -- the next generation of anti-TNF-alpha-therapy?].
Heidemann J; Kucharzik T
Z Gastroenterol; 2005 Jul; 43(7):689-90. PubMed ID: 16001352
[No Abstract] [Full Text] [Related]
8. Infliximab.
Valle E; Gross M; Bickston SJ
Expert Opin Pharmacother; 2001 Jun; 2(6):1015-25. PubMed ID: 11585004
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease.
Bell S; Kamm MA
Lancet; 2000 Mar; 355(9207):858-60. PubMed ID: 10752696
[No Abstract] [Full Text] [Related]
10. Retinal vein thrombosis after infliximab (Remicade) treatment for Crohn's disease.
Puli SR; Benage DD
Am J Gastroenterol; 2003 Apr; 98(4):939-40. PubMed ID: 12738486
[No Abstract] [Full Text] [Related]
11. Anti-TNF therapy for Crohn's disease: a perspective (infliximab is not the drug we have been waiting for).
Shanahan F
Inflamm Bowel Dis; 2000 May; 6(2):137-9. PubMed ID: 10833074
[No Abstract] [Full Text] [Related]
12. Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease.
Panagi S; Palka W; Korelitz BI; Taskin M; Lessnau KD
Inflamm Bowel Dis; 2004 May; 10(3):274-7. PubMed ID: 15290924
[TBL] [Abstract][Full Text] [Related]
13. Pericarditis as a complication of infliximab therapy in Crohn's disease.
Burke JP; Kelleher B; Ramadan S; Quinlan M; Sugrue D; O'Donovan MA
Inflamm Bowel Dis; 2008 Mar; 14(3):428-9. PubMed ID: 17924565
[No Abstract] [Full Text] [Related]
14. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
Keating GM; Perry CM
BioDrugs; 2002; 16(2):111-48. PubMed ID: 11985485
[TBL] [Abstract][Full Text] [Related]
15. Discussion on predictors of response to infliximab in patients with Crohn's disease.
Hommes D
Gastroenterology; 2003 Jun; 124(7):2002-3. PubMed ID: 12812196
[No Abstract] [Full Text] [Related]
16. Infliximab in Crohn's disease.
Rodrigo Saéz L
Rev Esp Enferm Dig; 2004 Jun; 96(6):359-63; 364-8. PubMed ID: 15230665
[No Abstract] [Full Text] [Related]
17. Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease.
Izbéki F; Nagy F; Szepes Z; Kiss I; Lonovics J; Molnár T
Inflamm Bowel Dis; 2008 Mar; 14(3):429-31. PubMed ID: 17973302
[No Abstract] [Full Text] [Related]
18. [Pharmacological profile of anti-human TNF alpha monoclonal antibody, infliximab (Remicade)].
Sugita T
Nihon Yakurigaku Zasshi; 2003 Jan; 121(1):57-64. PubMed ID: 12617039
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of refractory esophageal Crohn's disease with infliximab.
Fefferman DS; Shah SA; Alsahlil M; Gelrud A; Falchulk KR; Farrell RJ
Dig Dis Sci; 2001 Aug; 46(8):1733-5. PubMed ID: 11508675
[No Abstract] [Full Text] [Related]
20. [Indications and results of infliximab in Crohn's disease].
Karoui S; Boubaker J; Filali A
Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
